| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-22834-1_9 |
| P698 | PubMed publication ID | 26428378 |
| P2093 | author name string | Martin Rowe | |
| David Nadal | |||
| Anna Lünemann | |||
| P2860 | cites work | Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells | Q24294987 |
| Galectin-9 functionally impairs natural killer cells in humans and mice | Q24317152 | ||
| Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus | Q24634814 | ||
| Regulation of immune responses by extracellular vesicles | Q27006748 | ||
| The role of RNAi and microRNAs in animal virus replication and antiviral immunity | Q27490179 | ||
| Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1 | Q27670894 | ||
| Epstein-Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4 | Q28365981 | ||
| The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output | Q28752465 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
| Functional delivery of viral miRNAs via exosomes | Q29619574 | ||
| Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 | Q33265945 | ||
| Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma | Q33319277 | ||
| Human natural killer cell development in secondary lymphoid tissues | Q33567199 | ||
| AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome | Q33640163 | ||
| Dendritic cells during Epstein Barr virus infection | Q33782152 | ||
| „Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell | Q33906475 | ||
| EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells | Q34002594 | ||
| Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity | Q34037685 | ||
| Viral latency and its regulation: lessons from the gamma-herpesviruses | Q34039189 | ||
| Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation | Q34059398 | ||
| Role for early-differentiated natural killer cells in infectious mononucleosis | Q34353708 | ||
| When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. | Q34380769 | ||
| Epstein Barr virus entry; kissing and conjugation | Q34405443 | ||
| BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression | Q34411841 | ||
| Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. | Q34501427 | ||
| An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection | Q34539785 | ||
| Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo | Q34553645 | ||
| Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 | ||
| Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. | Q34619694 | ||
| Host innate immune receptors and beyond: making sense of microbial infections | Q34785533 | ||
| Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells | Q34874654 | ||
| Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling | Q35105647 | ||
| Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells | Q35181445 | ||
| Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection | Q35202828 | ||
| Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium | Q35857752 | ||
| Epstein-Barr virus immunossuppression of innate immunity mediated by phagocytes | Q36424417 | ||
| Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students | Q36471071 | ||
| Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma | Q36492390 | ||
| Natural killer cells act as rheostats modulating antiviral T cells | Q36517134 | ||
| Neutrophil in viral infections, friend or foe? | Q36569374 | ||
| Epstein-Barr virus transcytosis through polarized oral epithelial cells | Q36978584 | ||
| Cytokine-induced memory-like natural killer cells | Q37100910 | ||
| Regulatory NK-cell functions in inflammation and autoimmunity | Q37260883 | ||
| A distinct subpopulation of human NK cells restricts B cell transformation by EBV. | Q37324222 | ||
| Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. | Q37327015 | ||
| Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection | Q37493561 | ||
| Natural killer cell deficiency | Q37567421 | ||
| Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection | Q37640854 | ||
| Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens | Q37710781 | ||
| Extracellular vesicles and their convergence with viral pathways | Q38034222 | ||
| Natural killer cell distribution and trafficking in human tissues. | Q38066484 | ||
| BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. | Q38133428 | ||
| Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory | Q38192810 | ||
| Genetics of Epstein-Barr virus microRNAs | Q38193956 | ||
| Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis | Q38237679 | ||
| Interactions between innate and adaptive lymphocytes. | Q38240762 | ||
| "Small Talk" in the Innate Immune System via RNA-Containing Extracellular Vesicles | Q38268636 | ||
| Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes | Q39077351 | ||
| Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation | Q39260511 | ||
| Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production | Q39277512 | ||
| Infection of primary human monocytes by Epstein-Barr virus | Q39589786 | ||
| Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus. | Q39609877 | ||
| EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. | Q39614564 | ||
| EBV latent membrane protein 1 is a negative regulator of TLR9. | Q39639091 | ||
| Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma | Q39646759 | ||
| TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. | Q39698190 | ||
| Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. | Q39805733 | ||
| Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification | Q39852028 | ||
| Toll-like receptors in tonsillar epithelial cells | Q39891312 | ||
| The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway | Q39898460 | ||
| Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. | Q39917652 | ||
| Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus | Q40112081 | ||
| Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. | Q40128636 | ||
| The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. | Q40213261 | ||
| EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. | Q40237206 | ||
| Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. | Q40870284 | ||
| Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells | Q41063107 | ||
| Epstein-Barr virus encoded microRNAs target SUMO-regulated cellular functions | Q41745576 | ||
| TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells | Q41935231 | ||
| Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells | Q42123554 | ||
| Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. | Q42360336 | ||
| Exosomes: Fit to deliver small RNA. | Q42380535 | ||
| Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses | Q42425012 | ||
| EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape | Q44092146 | ||
| Localization of the Epstein-Barr virus protein LMP 1 to exosomes | Q45237056 | ||
| Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. | Q45356074 | ||
| Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes | Q45373069 | ||
| Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication | Q45572974 | ||
| Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. | Q45732708 | ||
| Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
| Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. | Q51888725 | ||
| T cell- and B cell-independent adaptive immunity mediated by natural killer cells. | Q51983250 | ||
| „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype | Q54628850 | ||
| The immune response to primary EBV infection: a role for natural killer cells | Q62583514 | ||
| Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans | Q74077692 | ||
| Adoptive immunotherapy for EBV-associated malignancies | Q81204067 | ||
| P304 | page(s) | 265-287 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Innate Immune Recognition of EBV. | |
| P478 | volume | 391 |
| Q40445972 | Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report |
| Q93018091 | Epstein-Barr Virus and Innate Immunity: Friends or Foes? |
| Q37673449 | Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes |
| Q39219487 | The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder |
Search more.